T1 Mapping in Fabry Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

T1 Mapping in Fabry Disease — Stella

Recruiting

Back to Fabry Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

France

Hopital Femme Mère Enfant, Bron

Hopital Edouard Herriot, Lyon

Key details

Sponsor

Hospices Civils de Lyon

Enrollment target

~70 participants

Started

August 2023

Primary completion

August 2026

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov